Company profile
Adagio Medical Holdings, Inc.
NASDAQ: ADGM · Healthcare · Medical - Devices
PublicHQ Laguna Hills, DECIK 0002006986Reports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
24DFH 31DQ 15GM 17SS 35
v0.1 · 65/100 weight · provisional
↑ growth stability, market scale · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$25.1M
Employees
41
as of 2026-08-22
Market cap
$14.4M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income-$25.1M-$25.1M2025
Operating income-$21.9M-$21.9M2025
Total assets$43.3M$43.3M2025
Liabilities$30.9M$30.9M2025
Equity$12.4M$12.4M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Adagio Medical Holdings, Inc.’s revenue?
Adagio Medical Holdings, Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Inhibitor Therapeutics, Inc.29DBiomind Labs Inc.——BioCardia, Inc.29DSynlogic, Inc.45DPhio Pharmaceuticals Corp.41DSatellos Bioscience Inc.——Key facts
CEOTodd Usen
SectorHealthcare
IndustryMedical - Devices
HeadquartersLaguna Hills, DE
ExchangeNASDAQ: ADGM
Employees41
IPO date2024-07-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.